Image
illustration
Growth & Buyout News

SGH HEALTHCARING increase Rovipharm's production capacity by 20%

Friday 25 March, 2022
Body

SGH Healthcaring announces an investment of € 8.2 million for the construction of a 650 sqm controlled atmosphere area on the Rovipharm Healthcaring site. Partly financed by the French government (as part of the “France Relance” recovery plan) and Agilent Technologies, this project will increase the company’s production capacity by 20%.

In December 2021, Rovipharm signed a contract with Agilent Technologies to produce 200 million cones with filters per year, which are consumables used for Covid PCR testing.